Updates in Medicine for Intensive Care

Dr Megan Fahy

ST5 Triple CCT Trainee in Intensive Care Medicine + Respiratory & General Internal Medicine, West Midlands Deanery

I am currently an ST4/5 speciality trainee in Respiratory, Intensive Care and General Internal Medicine in West Midlands Deanery. After studying medicine at Bristol University as a postgraduate, I completed my initial training in Wessex deanery. My interest includes education education, having completed my PGCert in Medical Education.

Professor Anna Olsson-Brown

Consultant Medical Oncologist, University Hospitals Sussex

Anna Olsson-Brown is a Professor of Clinical Cancer Trials and a Consultant in Medical Oncology. She specialises in the systemic treatment of skin cancers; immunotherapeutic toxicities, early phase/translational clinical trials and NSS/CUP/acute oncology. She is an academic consultant at University College Cork/Cork University Hospital and has roles in the UK as an honorary academic at the University of Liverpool, a consultant in Onco/Immunotoxicity and has held clinical leadership roles within the Cancer Alliance network.

She has a background in clinical pharmacology and an interest in acute oncology and supportive care for cancer patients particularly with regards to toxicity of cancer therapies. She was an MRC research fellow completing her PhD investigating the mechanisms of immunotherapy toxicity and has subsequently published extensively in the area (Olsson-Brown – Search Results – PubMed (nih.gov)).

She has established and led numerous acute and supportive oncology services including  pan-tumour, pan-regional immunotherapy/oncotoxicity service supporting inpatients and outpatients with immunotherapy toxicities and providing a clinical-research interface supporting a number of translational trials at both the Clatterbridge Cancer Centre, Liverpool and Sussex Cancer Centre, University Hospitals Sussex NHS Foundation Trust. She sits on number of advisory panels including the Cardio-oncology MDT at the Liverpool Heart and Chest Hospital and Neuro-oncology toxicity and HLH MDTs at University College London Hospital. She has established both an enhanced supportive care service and an oncofraility service at UHSx. She spent 4 years as an Clinical Director in healthcare prior to taking up her academic position.

She is the current Chair of the UK Society of Medical Oncology (formerly the Association of Cancer Physicians ACP). She is a founding member and current CEO of the National Immunotherapy Clinical Network (IOCN). She is also the Toxicity Workstream Co-lead within the UK Acute Oncology Society and a trustee and board member of UKASCC.  She is a Fellow of the Royal College of Physicians of Edinburgh and the current Oncology representative of the Symposium Committee at RCPE. She sits on the UK SACT board and RCP Oncology Committees in her representative roles.

Gemma Talling

ST7 Dual CCT Trainee Intensive Care Medicine + Anaesthesia, West Midlands Deanery

Dr Gemma Talling is a final-year Dual Trainee in Intensive Care Medicine and Anaesthesia. She developed an early passion for critical care, inspired by the calm leadership and teamwork at the heart of intensive care medicine.

Gemma is actively involved in regional and national critical care education, teaching across a range of courses and study days, with a particular passion for helping clinicians build confidence in managing critically ill patients. Alongside her educational roles and national work with FICM trainee committees, she is a strong advocate for supportive and inclusive training environments. She loves the challenge, teamwork, and privilege of working in intensive care medicine.